Corcept Therapeutics Incorporated shares owned by Invesco
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Invesco
from 13F filings
Historical chart of Invesco investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Invesco consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Invesco
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $61M | 733k | 83.00 |
| 2025-06-30 | $75M | 1.0M | 73.00 |
| 2025-03-31 | $142M | 1.2M | 114.00 |
| 2024-12-31 | $35M | 706k | 50.00 |
| 2024-09-30 | $39M | 857k | 46.00 |
| 2024-06-30 | $21M | 665k | 32.00 |
| 2024-03-31 | $19M | 770k | 25.00 |
| 2023-12-31 | $22M | 677k | 32.00 |
| 2023-09-30 | $26M | 946k | 27.00 |
| 2023-06-30 | $21M | 946k | 22.00 |
| 2023-03-31 | $24M | 1.1M | 21.50 |
| 2022-12-31 | $20M | 994k | 20.50 |
| 2022-03-31 | $0 | 1.1M | 0.00 |
| 2021-12-31 | $21M | 1.1M | 19.83 |
| 2021-09-30 | $28M | 1.4M | 19.67 |
| 2021-06-30 | $28M | 1.3M | 21.99 |
| 2021-03-31 | $27M | 1.1M | 23.82 |
| 2020-12-31 | $30M | 1.1M | 26.17 |
| 2020-09-30 | $40M | 2.3M | 17.43 |
| 2020-06-30 | $23M | 1.3M | 16.82 |
| 2020-03-31 | $16M | 1.4M | 11.88 |
| 2019-12-31 | $24M | 2.0M | 12.12 |
| 2019-09-30 | $20M | 1.4M | 14.14 |
| 2019-03-31 | $25M | 2.2M | 11.73 |
| 2018-12-31 | $29M | 2.2M | 13.37 |
| 2018-09-30 | $39M | 2.8M | 14.03 |
| 2018-06-30 | $29M | 1.8M | 15.72 |
| 2018-03-31 | $25M | 1.5M | 16.45 |
| 2017-12-31 | $36M | 2.0M | 18.06 |
| 2017-09-30 | $38M | 2.0M | 19.30 |
| 2017-06-30 | $28M | 2.4M | 11.80 |
| 2017-03-31 | $14M | 1.3M | 10.96 |
| 2016-12-31 | $9.6M | 1.3M | 7.19 |
| 2016-09-30 | $9.4M | 1.4M | 6.49 |
| 2016-06-30 | $7.3M | 1.3M | 5.47 |
| 2016-03-31 | $889k | 190k | 4.68 |
| 2015-12-31 | $78k | 16k | 4.97 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated